Scrip
Novartis building Chinese presence with vaccines acquisition and R&D investment
05 November 2009
Ian Haydock
Novartis has become the latest multinational to set its sights on the fast-growing vaccines market in China, where it has unveiled plans to acquire a Chinese manufacturer, and is also investing $1 billion over the next five years to build up its R&D operations in the country.
The Swiss...
Please Login to read the full article.
05 November 2009
Ian Haydock
The Swiss...
Please Login to read the full article.
RELATED CONTENT
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
10 February 2010
London, UK
11 February 2010
London, UK
23 February 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
